ClinicalTrials.gg
Sign In
RecruitingNCT06603415Updated Sep 19, 2024

Hashimoto's Thyroiditis in Upper Egypt

An interventional study of Total thyroidectomy in Hashimoto's Thyroiditis, sponsored by Sohag University. Recruiting at 2 sites in Egypt. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Sex
All
01

Study summary

The aim of this study is to evaluate the pathological pattern, characteristic features, treatment, complications and prognosis of Hashimoto's thyroiditis in upper Egypt.

02

Conditions studied

  • Hashimoto's Thyroiditis

Browse trials for

03

In context

Hashimoto Disease

53 studies on the registry are indexed under Hashimoto Disease; 13 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 31 interventional studies indexed under Hashimoto Disease.

Browse Hashimoto Disease studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Browse Sohag University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients with Hashimoto's thyroiditis, males or females, any age, at upper egypt .

Exclusion criteria

Exclusion Criteria:

  • Patients with associated other thyroid pathology other than Hashimoto's thyroiditis.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Other
    PATTERN OF HASHIMOTO'S THYROIDITIS IN UPPER EGYPT

    the pathological pattern, characteristics, treatment, complications and prognosis of Hashimoto's thyroiditis in upper egypt .

    Procedure: Total thyroidectomy

Interventions

  • ProcedureTotal thyroidectomy

    Total thyroidectomy (with preservation of bilateral recurrent laryngeal nerves and all parathroid glands) for histopathology

06

What researchers measure

Primary outcomes

  1. Early post operative follow up of Hashimoto's thyroiditis

    Removal of suction drains

    Time frame: 3 days after the operation

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Feldt-Rasmussen U. Hashimoto's thyroiditis as a risk factor for thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):364-371. doi: 10.1097/MED.0000000000000570. PubMed 32773575 ↗
  • Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005 Oct;71(10):874-8. PubMed 16468540 ↗
  • Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998 Mar;8(3):197-202. doi: 10.1089/thy.1998.8.197. PubMed 9545105 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06603415
Lead sponsor
Sohag University
Responsible party
Hossam Mohamed Araby (Resident, Department of General Surgery, Faculty of Medicine, Sohag University, Sohag University) — Principal investigator
First posted
Sep 19, 2024
Start date
Jul 15, 2024
Primary completion
Jun 1, 2025 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Hossam M Araby, Resident
Contact
hossam.araby07@gmail.com
+201158973535
Kamal A Mohamed, Professor
Contact
01006193655

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hashimoto Disease →

Other studies from this sponsor

Sohag University →

Start the discussion